MCI Through the Years
• President Gordon Moulton commissions feasibility study for Cancer Research Institute.
• The commissioned consulting firm, Oncology Solutions, demonstrates need for academic cancer center serving the upper Gulf Coast Corridor, with a potential catchment area encompassing major portions of Florida, Alabama, Mississippi and Louisiana.
• USA Board of Trustees votes unanimously to support creation of USA Cancer Research Institute, representing the single largest research commitment in the University’s history.
2000 - 2002
• USA receives Tobacco Suit Settlement Funds in the amount of $3,870,000, used as seed money to initiate development of USA Cancer Research Institute.
• President Gordon Moulton and leadership within USA Board of Trustees spearheaded by Mr. Mayer Mitchell, engage Alabama Senators and Congressmen in advocating/securing federal appropriations to support establishment of USA Cancer Research Institute.
• USA initiates national search for Director of USA-CRI in 2001.
• USA purchases PET/CT scanner through federal appropriations to support cancer-related diagnostic imaging at USA Knollwood Park Hospital.
• Dr. Boyd joins USA Cancer Research Institute, as first employee and Director, on April 1, 2002.
• Dr. Michael Boyd recruits first USA-CRI faculty: Dr. Lewis Pannell from NIH, Dr. Oystein Fodstad and Dr. Steinar Aamdal, from Norwegian Radium Hospital.
• USA-CRI initiates basic/translational cancer research activities within space leased from College of Medicine on USA campus.
• Alabama State Bond Commission votes to approve $12 million to USA to help create USA-CRI.
• USA, through $12 million state monies and federal appropriations, initiates first-phase building plans.
• March 2003: USA selects architect through competitive RFP process, to design USA-CRI for construction on USA Knollwood Park Hospital Campus.
• USA-CRI continues recruitment of USA-CRI faculty and staff; as of December 31, 2003, USA-CRI employees total 25.
• USA-CRI recruits Dr. Philip Wade as Chief, Medical Oncology, and Dr. Hung Khong as Physician-Scientist from NCI; first USA-CRI medical oncology clinic opens in leased space on USA Knollwood Park Hospital Campus.
• Recruitment of scientific faculty and staff accelerates.
• USA publicly announces plans to begin construction of a 120,000 square foot building on USA Knollwood Park campus.
• USA Foundation provides $1.5 million for USA-CRI and pledges total of $12 million to help build USA-CRI.
• June 2004: USA unveils architectural drawings of the new USA-CRI facility; USA-CRI announces recruitment of five additional cancer physicians and researchers.
• USA secures over $46 million to support USA-CRI, from direct federal appropriations, state economic development funding, USA Foundation support and other donations.
• July 2004: Mobile City and Mobile County vote to support USA-CRI, with each entity committing $6 million.
• USA-CRI appoints Dr. Joseph LoCicero (USA College of Medicine Department of Surgery Chair) as director of “Center for Clinical Oncology” of USA-CRI.
• As of December 31, 2004, USA-CRI full-time employees total 40.
• Groundbreaking ceremony for USA-CRI occurs on April 11 at USA Knollwood Hospital site; many local, state and federal dignitaries and over 600 faculty, staff, students and community supporters attend.
• May 2005: Construction of USA-CRI begins with site-prep work at Knollwood site.
• USA President Gordon Moulton and Infirmary Health System President and CEO Chandler Bramlett sign memorandum of understanding in July 2005, for developing a strategic healthcare alliance, including relocation of USA-CRI construction site to land adjacent to Mobile Infirmary Medical Center (MIMC) and USA Children’s and Women’s Hospital (C&W); site-prep work at Knollwood site ceases.
• USA-CRI recruits Chief of Radiation Oncology, Raymond Wynn, and creates an academic radiation oncology division within USA-CRI.
• Dr. LoCicero departs USA.
• USA-MCI relocated organizationally under Office of the President.
• As of December 31, 2005, USA-CRI employees total approximately 60.
• USA-CRI recruits Dr. Adam Riker from Moffitt as Chief of Surgical Oncology at USA-CRI and establishes USA-MCI Surgical Oncology Service; USA-MCI recruits second Surgical Oncologist, Dr. Matthew D’Alessio.
• Construction resumes for USA-CRI at new site, with first-phase budget at $80 million for 125,000 GSF clinical and research facility.
• March 2006: The Mitchell family pledges $22 million to support development of USA’s Cancer Research Institute.
• USA Board of Trustees vote to rename the USA-CRI the “Mitchell Cancer Institute” in honor of the Mitchell family’s commitment.
• USA-MCI receives grant to enhance cervical cancer screening rates among Asian women living in Bayou la Batre, Alabama.
• USA-MCI launches Skin Cancer Screening/Prevention Program.
• As of December 31, 2006, USA-MCI employees total approximately 85.
• Construction of USA-MCI building underway.
• Basic and Translational Research Grant portfolio continues to expand.
• May 2007: USA-MCI reaches 100-employee mark and receives cumulatively more than $125 million in charitable, state and federal funding.
• June 2007: USA-MCI Gynecologic Oncology Service begins with the recruitment of Drs. Michael Finan and Rodney Rocconi.
• USA-MCI Medical, GYN & Surgical Oncology Programs relocated to leased interim space on Mobile Infirmary campus.
• USA Board of Trustees approves creation of USA-MCI mission-specific primary faculty tracks (Oncologic Sciences and Interdisciplinary Clinical Oncology) within USA-MCI.
• Dr. and Mrs. Michael Boyd announce $2 million gift to USA-MCI.
• The Community Foundation of South Alabama provides largest outreach grant in its history to fund cancer screenings through USA-MCI.
• September: USA-MCI opens the doors to its new 125,000 GSF facility.
• President and Mrs. Gordon Moulton pledge $3,000,000 to USA-MCI
• November: USA hosts grand opening of USA-MCI with over 1,000 attendees.
• Dr. Laurie Owen, Ph.D. joins USA-MCI as Barbara Colle Chair and Associate Director, Basic & Translational Sciences and Professor of Oncologic Sciences, USA Mitchell Cancer Institute
• Dr. Eddie Reed, joins USA-MCI as Point Clear Charities Chair and Associate Director, Cancer Prevention and Control, Professor of Oncologic Sciences, and Abraham Mitchell Distinguished Investigator, USA Mitchell Cancer Institute
• Surgical Oncology Program proves financially non-viable at USA-MCI; Dr. Riker departs to accept position at Oschner Cancer Institute (New Orleans) as medical director of cancer services.
• USAMC hires private medical oncology group practicing at Mobile Infirmary Medical Center/Thomas Hospital in April 2009, thereby consolidating medical oncology services at USA-MCI.
• April 2010: USA-MCI acquires Radiation Oncology Department from MIMC, consolidating radiation oncology services under USA-MCI Department of Radiation Oncology; Dr. John R. Russell joins USA-MCI as Chair of Department.
• August 2010: Dr. Suzanne Russo and Dr. Roger Ove join USA-MCI Department of Radiation Oncology.
• Negotiations ensue to assimilate Southern Cancer Center, the largest community-based, private medical oncology group in the region, but ultimately fail to result in acquisition.
• Swift Biotechnology Company is formed as result of clinical/ scientific collaborations at USA-MCI resulting in promising technology for early detection of ovarian and endometrial cancers.
• First and second annual “Celebrate Hope” fundraising events held at MCI in November 2009 and November 2010.
• As of December 31, 2009, USA-MCI employees total approximately 165; as of December 31, 2010, USA-MCI employees total approximately 190.
• Dr. Bruce Chabner agrees to head MCI Executive Advisory Board.
• USA-MCI initiates new patient-centered activities including Care Notebook, bffl TM bags, patient satisfaction surveys and support groups.
• Third annual “Celebrate Hope” event raises over $300,000, with cumulative net raised after 3 annual events totaling over $789,000.
• Dr. Windy Dean-Colomb from M.D. Anderson joins USA-MCI medical oncology service.
• USA-MCI appoints Dr. Rodney Rocconi as Deputy Associate Director for Clinical Research.
• USA-MCI receives additional $3,000,000/year in state appropriation, for total of $5,000,000/year in state appropriation.
• USA-MCI implements oncology-specific Electronic Medical Record.
• Business development and outreach efforts are formalized and expanded.
• USA-MCI researchers partner with Boston-based biotech firm to advance pancreatic cancer research
• USA-MCI establishes Drug Discovery Research Center with team headed by Dr. Gary Piazza.
• 6,000 patients treated; patient visits exceed 55,000.
• Member physicians reach total of 32.
• Third GYN Oncologist, Dr. Jennifer Scalici, joins GYN service.
• Dr. Carole Wisemen-Norden joins Medical Oncology Service.
• First site-visit review of MCI by Executive Advisory Board scheduled for October 24-26.
• Dr. Eddie Reed recruited by NIH to new position of Clinical Director, National Institute of Minority Health and Health Disparities.
• Preliminary discussions begin between USA-MCI and UAB Comprehensive Cancer Center to enter into a Cancer Consortium partnership.
• Currently, USA-MCI employees total approximately 300.
• In March the USA Board of Trustees approves the Cancer Consortium partnership between USA-MCI and UAB-CCC in a declaration of intent, endorsed by both universities. Consortium partnership activities begin immediately as the two institutions forge productive collaborations to advance and accelerate clinical, translational and basic cancer research.